[Cellular pharmacokinetics of melphalan alone or in combination on human lymphoma or lymphoblasts].
Sapet
C
C
Laboratoire de pharmacocinétique, centre Léon-Bérard, Lyon, France.
Tranchand
B
B
Navarro
C
C
Ardiet
C
C
D000963:Antimetabolites / Q000494:pharmacology; D001757:Blastomeres / Q000187:drug effects; D002051:Burkitt Lymphoma / Q000188:drug therapy / Q000378:metabolism* / Q000473:pathology; D019328:Buthionine Sulfoximine; D002460:Cell Line; D005047:Etoposide / Q000494:pharmacology; D006801:Humans; D008214:Lymphocytes / Q000187:drug effects* / Q000378:metabolism; D008558:Melphalan / Q000493:pharmacokinetics*; D008717:Methionine Sulfoximine / Q000031:analogs & derivatives / Q000494:pharmacology; D014700:Verapamil / Q000494:pharmacology
D000963:Antimetabolites; D008717:Methionine Sulfoximine; D019328:Buthionine Sulfoximine; D005047:Etoposide; D014700:Verapamil; D008558:Melphalan
Pharmacocinétique cellulaire du melphalan seul ou en association sur lymphomes ou lymphoblastes humains.